Detection of Bacterial α-l-Fucosidases with an


Journal

Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009

Informations de publication

Date de publication:
28 Feb 2022
Historique:
received: 26 01 2022
revised: 14 02 2022
accepted: 17 02 2022
entrez: 10 3 2022
pubmed: 11 3 2022
medline: 1 4 2022
Statut: epublish

Résumé

Fucosidases are associated with several pathological conditions and play an important role in the health of the human gut. For example, fucosidases have been shown to be indicators and/or involved in hepatocellular carcinoma, breast cancer, and helicobacter pylori infections. A prerequisite for the detection and profiling of fucosidases is the formation of a specific covalent linkage between the enzyme of interest and the activity-based probe (ABP). The most commonly used fucosidase ABPs are limited to only one of the classes of fucosidases, the retaining fucosidases. New approaches are needed that allow for the detection of the second class of fucosidases, the inverting type. Here, we report an

Identifiants

pubmed: 35268716
pii: molecules27051615
doi: 10.3390/molecules27051615
pmc: PMC8911971
pii:
doi:

Substances chimiques

Indolequinones 0
quinone methide 138230-21-4
alpha-L-Fucosidase EC 3.2.1.51

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : The Netherlands Organization for Scientific Research
ID : VIDI grant 723.014.005
Organisme : The Netherlands Organization for Scientific Research
ID : VI.Veni.192.058
Organisme : European Research Council
ID : ERC-2019-STG-852452
Pays : International

Références

Oncotarget. 2015 Aug 28;6(25):21283-300
pubmed: 26204487
Chembiochem. 2015 Jul 27;16(11):1555-9
pubmed: 26096673
Curr Opin Chem Biol. 2019 Dec;53:25-36
pubmed: 31419756
ACS Chem Biol. 2017 Jan 20;12(1):63-72
pubmed: 28103685
J Biol Chem. 1970 May 10;245(9):2247-54
pubmed: 5442270
Proc Natl Acad Sci U S A. 2009 Aug 25;106(34):14581-6
pubmed: 19666478
Proc Natl Acad Sci U S A. 2011 Apr 26;108(17):7194-9
pubmed: 21482772
J Bacteriol. 2004 Aug;186(15):4885-93
pubmed: 15262925
Bioconjug Chem. 2020 Jul 15;31(7):1740-1744
pubmed: 32538077
Nat Protoc. 2006;1(4):1852-8
pubmed: 17487168
J Biol Chem. 2004 Oct 22;279(43):44704-12
pubmed: 15308675
Front Microbiol. 2019 Aug 27;10:1756
pubmed: 31507539
Mucosal Immunol. 2019 Jan;12(1):1-9
pubmed: 29988120
J Biol Chem. 1988 Jun 15;263(17):7929-32
pubmed: 3286645
Methods Enzymol. 2018;598:237-265
pubmed: 29306437
Biochemistry. 2005 Sep 6;44(35):11669-75
pubmed: 16128567
Chem Sci. 2015 May 1;6(5):2782-false
pubmed: 29142681
J Immunol. 2015 Jun 15;194(12):5588-93
pubmed: 26048966
Cell Mol Life Sci. 2021 Jan;78(2):675-693
pubmed: 32333083
Br J Cancer. 2014 Apr 2;110(7):1811-9
pubmed: 24569461
Molecules. 2020 Dec 18;25(24):
pubmed: 33352858
J Am Chem Soc. 2012 Dec 19;134(50):20521-32
pubmed: 23176123
Commun Biol. 2020 Jan 7;3(1):2
pubmed: 31925306
Angew Chem Int Ed Engl. 2011 Jan 3;50(1):300-3
pubmed: 21184404
Cell Microbiol. 2020 Dec;22(12):e13252
pubmed: 32827216
J Org Chem. 2015 Aug 21;80(16):8458-63
pubmed: 26240938
Sci Rep. 2018 May 15;8(1):7583
pubmed: 29765093

Auteurs

Yvette M C A Luijkx (YMCA)

Department Chemical Biology and Drug Discovery, Utrecht Institute for Pharmaceutical Sciences, Bijvoet Center for Biomolecular Research, Utrecht University, Universiteitswg 99, 3584 CG Utrecht, The Netherlands.

Anniek J Henselijn (AJ)

Department Chemical Biology and Drug Discovery, Utrecht Institute for Pharmaceutical Sciences, Bijvoet Center for Biomolecular Research, Utrecht University, Universiteitswg 99, 3584 CG Utrecht, The Netherlands.

Gerlof P Bosman (GP)

Department Chemical Biology and Drug Discovery, Utrecht Institute for Pharmaceutical Sciences, Bijvoet Center for Biomolecular Research, Utrecht University, Universiteitswg 99, 3584 CG Utrecht, The Netherlands.

Dario A T Cramer (DAT)

Department Biomolecular Mass Spectrometry and Proteomics, Utrecht Institute for Pharmaceutical Sciences, Bijvoet Center for Biomolecular Research, Utrecht University, 3584 CH Utrecht, The Netherlands.
Netherlands Proteomics Centre, 3584 CH Utrecht, The Netherlands.

Koen C A P Giesbers (KCAP)

Department Biomolecular Health Sciences, Division Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, Yalelaan 1, 3584 CL Utrecht, The Netherlands.

Esther M van 't Veld (EM)

Department Biomolecular Health Sciences, Centre for Cell Imaging, Faculty of Veterinary Medicine, Utrecht University, Yalelaan 1, 3584 CL Utrecht, The Netherlands.

Geert-Jan Boons (GJ)

Department Chemical Biology and Drug Discovery, Utrecht Institute for Pharmaceutical Sciences, Bijvoet Center for Biomolecular Research, Utrecht University, Universiteitswg 99, 3584 CG Utrecht, The Netherlands.
Complex Carbohydrate Research Center, University of Georgia, Athens, GA 30602, USA.

Albert J R Heck (AJR)

Department Biomolecular Mass Spectrometry and Proteomics, Utrecht Institute for Pharmaceutical Sciences, Bijvoet Center for Biomolecular Research, Utrecht University, 3584 CH Utrecht, The Netherlands.
Netherlands Proteomics Centre, 3584 CH Utrecht, The Netherlands.

Karli R Reiding (KR)

Department Biomolecular Mass Spectrometry and Proteomics, Utrecht Institute for Pharmaceutical Sciences, Bijvoet Center for Biomolecular Research, Utrecht University, 3584 CH Utrecht, The Netherlands.
Netherlands Proteomics Centre, 3584 CH Utrecht, The Netherlands.

Karin Strijbis (K)

Department Biomolecular Health Sciences, Division Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, Yalelaan 1, 3584 CL Utrecht, The Netherlands.

Tom Wennekes (T)

Department Chemical Biology and Drug Discovery, Utrecht Institute for Pharmaceutical Sciences, Bijvoet Center for Biomolecular Research, Utrecht University, Universiteitswg 99, 3584 CG Utrecht, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH